One of the best-studied channelopathies is Brugada Syndrome, in which 20 to 25% of cases are due to a disease-associated variant in SCN5A (3); this gene encodes for NaV1.5, the pore-forming α subunit of the major cardiac NaV channel (4, 5). This evidence concerns the gene SCN5A and channelopathy.